On Wednesday, October 22, 2025 at 1:00 p.m. ET, join ALS Canada for our next ALS Clinical Trials Unboxed webinar to learn more about ongoing ALS clinical trials.
In this webinar, Dr. Oren Levy, Medical Director in the Genetics Medicines Unit of Regeneron Pharmaceuticals will present on the ALN-SOD clinical trial – a study that will evaluate the safety and tolerability of ALN-SOD in people with SOD1-ALS.
This free webinar will be approximately half an hour and will be followed by a Q&A period. Please submit any questions you have through the registration form.
Please note that ALS Canada does not provide medical advice or make referrals related to drug therapies or alternative therapies. These questions should be discussed directly with a medical professional – ideally an ALS neurologist, who would be qualified to interpret clinical information for individual situations.
Please visit our list of ALS clinics to help you to connect with a clinic in your area.